Sinopia Biosciences is transforming drug discovery and illness research. For the past thirty years, target-based drug discovery has been the predominant method. However, phenotypic screening has shown greater productivity in the discovery of first-in-class medications due to the fact that the pathogenesis of many diseases is often complex and the